Johansen Jeanette Schultz, Westergren Tone, Lingaas Egil
Avdeling for smittevern, Oslo universitetssykehus, Rikshospitalet, Norway.
Tidsskr Nor Laegeforen. 2011 Sep 6;131(17):1645-8. doi: 10.4045/tidsskr.10.0149.
Varicella may have a serious and sometimes fatal course, especially in immunocompromised patients. Some patient groups may need prophylaxis after exposure to the varicella-zoster-virus. In this article we review the evidence for usefulness of prophylactic measures after such exposure.
The article is based on a non-systematic literature search in Medline, the Cochrane Library, UpToDate and Clinical Evidence.
The effect of post-exposure varicella prophylaxis on disease rate and severity of varicella is only weakly documented. There is some evidence that passive immunisation with varicella-zoster immunoglobulin (VZIG) reduces the risk of serious disease when it is administered within 72-96 hours after exposure. Several studies of mostly healthy children have shown that prophylactic acyclovir is better than control treatment, but the studies are small and they are not properly designed. Post-exposure vaccination is shown to reduce disease rate and severity in otherwise healthy children.
We believe that acyclovir or valacyclovir can be used as post-exposure varicella prophylaxis in risk patients for whom the time window for VZIG-use has expired.
水痘可能有严重甚至致命的病程,尤其是在免疫功能低下的患者中。一些患者群体在接触水痘 - 带状疱疹病毒后可能需要进行预防。在本文中,我们回顾了接触病毒后预防措施有效性的证据。
本文基于对医学文献数据库(Medline)、考克兰图书馆、UpToDate和临床证据库进行的非系统性文献检索。
接触后水痘预防措施对水痘发病率和严重程度的影响仅有微弱的文献记载。有证据表明,在接触后72 - 96小时内给予水痘 - 带状疱疹免疫球蛋白(VZIG)进行被动免疫可降低患严重疾病的风险。多项主要针对健康儿童的研究表明,预防性使用阿昔洛韦优于对照治疗,但这些研究规模较小且设计不够合理。接触后接种疫苗可降低健康儿童的发病率和严重程度。
我们认为,对于VZIG使用时间窗已过的高危患者,阿昔洛韦或伐昔洛韦可用于接触后水痘的预防。